Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tomáš Wolaschka"'
Autor:
Ľudmila Balážová, Tomáš Wolaschka, Simona Rohaľová, Nina Daneu, Martin Stahorský, Aneta Salayová, Ľudmila Tkáčiková, Jarmila Eftimová
Publikováno v:
Life, Vol 13, Iss 2, p 573 (2023)
Silver nanoparticles (Ag NPs) with antibacterial activity can be prepared in different ways. In our case, we used ecological green synthesis with Agrimonia eupatoria L. The plant extract was used with Ag NPs for the first time to prepare termosensiti
Externí odkaz:
https://doaj.org/article/03331e03be4648b28ae17299a4f6028f
Autor:
Tomáš, Wolaschka
Publikováno v:
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 68(1)
Transdermal Therapeutic Systems (TTS) improve patient compliance especially due to its simple application and long-term action with the need to exchange the system every 12 hours to several days. The advantages also include elimination of first-pass
Autor:
Sylvie Pavloková, Tomáš Wolaschka, Slavomír Kurhajec, Klára Kostelanská, David Vetchý, Aleš Franc, Jan Gajdziok
Publikováno v:
Journal of Drug Delivery Science and Technology. 60:102022
Plant extracts with antioxidant activity are an important source of natural drugs. Usually are used as liquids, which are voluminous and often unstable. To overcome these obstacles, fast disintegrating tablets with high content of antioxidants were p
Autor:
Ladislav Mirossay, Jana Blažejová, Martina Čižmáriková, Dana Potočeková, Helena Baumohlová, Juraj Bober, Lívia Kipikašová, Marek Šarišský, Ján Mojžiš, Peter Bohus, Andrej Mirossay, Tomáš Wolaschka
Publikováno v:
Pathology oncology research : POR. 14(2)
The purpose of this case control study was to evaluate the role of X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genotypes as genetic indicators of susceptibility to breast cancer (BC). We analysed DNA sampl